AstraZeneca Pharma India Ltd. — Board/Management Information 2023

May 22, 2023

==> picture [524 x 91] intentionally omitted <==

May 22, 2023

The Manager - Listing

National Stock Exchange of India Ltd.

Exchange plaza, 5[th] Floor, Plot No. C/1, G Block Bandra-Kurla Complex, Bandra (E), Mumbai 400051

The Manager - Listing BSE Limited

Corporate Relationship Dept., 1[st] Floor, New Trading Ring Rotunda Building, P J Towers, Dalal Street, Fort, Mumbai 400001

Dear Sirs,

Sub: Meeting of the Board of Directors of the Company to be held on Tuesday, May 30, 2023 – Ref: Scrip Code BSE: 506820, NSE: ASTRAZEN

This is to inform that a Meeting of the Board of Directors of AstraZeneca Pharma India Limited will be held on Tuesday, May 30, 2023 inter alia:

1. To consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2023.

2. To recommend Dividend, if any, on the Equity Shares of the Company for the Financial Year 2022-23.

We also inform you that the ‘Trading Window’ remains closed for all Designated Persons, from March 16, 2023 to June 1, 2023 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

We request you to please take the same on record.

Thanking you,

Yours faithfully,

For AstraZeneca Pharma India Limited

MANASA Digitally signed by MANASA RAMA RAMA Date: 2023.05.22 10:55:19 +05'30'

Manasa. R Company Secretary

==> picture [452 x 64] intentionally omitted <==